These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 36839280)

  • 1. The Role of Gut Microbiota in High-Fat-Diet-Induced Diabetes: Lessons from Animal Models and Humans.
    Qi Y; Wang X
    Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiome and type 2 diabetes: where we are and where to go?
    Sharma S; Tripathi P
    J Nutr Biochem; 2019 Jan; 63():101-108. PubMed ID: 30366260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut Microbiota Mediates the Protective Effects of Dietary Capsaicin against Chronic Low-Grade Inflammation and Associated Obesity Induced by High-Fat Diet.
    Kang C; Wang B; Kaliannan K; Wang X; Lang H; Hui S; Huang L; Zhang Y; Zhou M; Chen M; Mi M
    mBio; 2017 May; 8(3):. PubMed ID: 28536285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut Microbiome Changes in Gestational Diabetes.
    Ionescu RF; Enache RM; Cretoiu SM; Gaspar BS
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of gut microbiota-derived extracellular vesicles on obesity and diabetes and their potential modulation through diet.
    Díez-Sainz E; Milagro FI; Riezu-Boj JI; Lorente-Cebrián S
    J Physiol Biochem; 2022 May; 78(2):485-499. PubMed ID: 34472032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota dysbiosis -associated obesity and its involvement in cardiovascular diseases and type 2 diabetes. A systematic review.
    Hamjane N; Mechita MB; Nourouti NG; Barakat A
    Microvasc Res; 2024 Jan; 151():104601. PubMed ID: 37690507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary Influences on Gut Microbiota with a Focus on Metabolic Syndrome.
    Thomas MS; Blesso CN; Calle MC; Chun OK; Puglisi M; Fernandez ML
    Metab Syndr Relat Disord; 2022 Oct; 20(8):429-439. PubMed ID: 35704900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fat and not sugar as the determining factor for gut microbiota changes, obesity, and related metabolic disorders in mice.
    Suriano F; Vieira-Silva S; Falony G; de Wouters d'Oplinter A; Paone P; Delzenne NM; Everard A; Raes J; Van Hul M; Cani PD
    Am J Physiol Endocrinol Metab; 2023 Jan; 324(1):E85-E96. PubMed ID: 36516223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex-specific association between the gut microbiome and high-fat diet-induced metabolic disorders in mice.
    Peng C; Xu X; Li Y; Li X; Yang X; Chen H; Zhu Y; Lu N; He C
    Biol Sex Differ; 2020 Jan; 11(1):5. PubMed ID: 31959230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial Effects of Non-Encapsulated or Encapsulated Probiotic Supplementation on Microbiota Composition, Intestinal Barrier Functions, Inflammatory Profiles, and Glucose Tolerance in High Fat Fed Rats.
    Lee S; Kirkland R; Grunewald ZI; Sun Q; Wicker L; de La Serre CB
    Nutrients; 2019 Aug; 11(9):. PubMed ID: 31443365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-37 sensitize the elderly type 2 diabetic patients to insulin therapy through suppressing the gut microbiota dysbiosis.
    Li T; Li H; Li W; Chen S; Feng T; Jiao W; Wu C; Dong J; Li Y; Li S; Feng M; Wei X
    Mol Immunol; 2019 Aug; 112():322-329. PubMed ID: 31238287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synbiotic Intervention with an Adlay-Based Prebiotic and Probiotics Improved Diet-Induced Metabolic Disturbance in Mice by Modulation of the Gut Microbiota.
    Chiou WC; Chang BH; Tien HH; Cai YL; Fan YC; Chen WJ; Chu HF; Chen YH; Huang C
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term high-fructose high-fat diet feeding elicits insulin resistance, exacerbates dyslipidemia and induces gut microbiota dysbiosis in WHHL rabbits.
    Moughaizel M; Dagher E; Jablaoui A; Thorin C; Rhimi M; Desfontis JC; Mallem Y
    PLoS One; 2022; 17(2):e0264215. PubMed ID: 35196347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut Microbiota and Complications of Type-2 Diabetes.
    Iatcu CO; Steen A; Covasa M
    Nutrients; 2021 Dec; 14(1):. PubMed ID: 35011044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
    Halmos T; Suba I
    Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there a role for gut microbiota in type 1 diabetes pathogenesis?
    Bibbò S; Dore MP; Pes GM; Delitala G; Delitala AP
    Ann Med; 2017 Feb; 49(1):11-22. PubMed ID: 27499366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α-Lactalbumin peptide Asp-Gln-Trp alleviates hepatic insulin resistance and modulates gut microbiota dysbiosis in high-fat diet-induced NAFLD mice.
    Chen H; Sun Y; Zhao H; Qi X; Cui H; Li Q; Ma Y
    Food Funct; 2022 Oct; 13(19):9878-9892. PubMed ID: 36052713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host Genotype and Gut Microbiome Modulate Insulin Secretion and Diet-Induced Metabolic Phenotypes.
    Kreznar JH; Keller MP; Traeger LL; Rabaglia ME; Schueler KL; Stapleton DS; Zhao W; Vivas EI; Yandell BS; Broman AT; Hagenbuch B; Attie AD; Rey FE
    Cell Rep; 2017 Feb; 18(7):1739-1750. PubMed ID: 28199845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.